Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU

Sandra L. Kane-Gill, Joseph F. Dasta, Mitchell S. Buckley, Sandeep Devabhakthuni, Michael Liu, Henry Cohen, Elizabeth L. George, Anne S. Pohlman, Swati Agarwal, Elizabeth A. Henneman, Sharon M. Bejian, Sean Berenholtz, Jodie L. Pepin, Mathew C. Scanlon, Brian S. Smith

Research output: Contribution to journalArticle

Abstract

This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

Original languageEnglish (US)
Pages (from-to)1546-1551
Number of pages6
JournalCritical Care Medicine
Volume45
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Medication Reconciliation
Practice Guidelines
Guidelines

Keywords

  • critical care intensive care unit
  • drug-related side effects and adverse reactions
  • medication errors
  • patient safety
  • safety management

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Kane-Gill, S. L., Dasta, J. F., Buckley, M. S., Devabhakthuni, S., Liu, M., Cohen, H., ... Smith, B. S. (2017). Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU. Critical Care Medicine, 45(9), 1546-1551. https://doi.org/10.1097/CCM.0000000000002519

Executive Summary : Clinical Practice Guideline: Safe Medication Use in the ICU. / Kane-Gill, Sandra L.; Dasta, Joseph F.; Buckley, Mitchell S.; Devabhakthuni, Sandeep; Liu, Michael; Cohen, Henry; George, Elizabeth L.; Pohlman, Anne S.; Agarwal, Swati; Henneman, Elizabeth A.; Bejian, Sharon M.; Berenholtz, Sean; Pepin, Jodie L.; Scanlon, Mathew C.; Smith, Brian S.

In: Critical Care Medicine, Vol. 45, No. 9, 01.09.2017, p. 1546-1551.

Research output: Contribution to journalArticle

Kane-Gill, SL, Dasta, JF, Buckley, MS, Devabhakthuni, S, Liu, M, Cohen, H, George, EL, Pohlman, AS, Agarwal, S, Henneman, EA, Bejian, SM, Berenholtz, S, Pepin, JL, Scanlon, MC & Smith, BS 2017, 'Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU', Critical Care Medicine, vol. 45, no. 9, pp. 1546-1551. https://doi.org/10.1097/CCM.0000000000002519
Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H et al. Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU. Critical Care Medicine. 2017 Sep 1;45(9):1546-1551. https://doi.org/10.1097/CCM.0000000000002519
Kane-Gill, Sandra L. ; Dasta, Joseph F. ; Buckley, Mitchell S. ; Devabhakthuni, Sandeep ; Liu, Michael ; Cohen, Henry ; George, Elizabeth L. ; Pohlman, Anne S. ; Agarwal, Swati ; Henneman, Elizabeth A. ; Bejian, Sharon M. ; Berenholtz, Sean ; Pepin, Jodie L. ; Scanlon, Mathew C. ; Smith, Brian S. / Executive Summary : Clinical Practice Guideline: Safe Medication Use in the ICU. In: Critical Care Medicine. 2017 ; Vol. 45, No. 9. pp. 1546-1551.
@article{dcf9a97ac53c4b09a42b25272ccfe7d1,
title = "Executive Summary: Clinical Practice Guideline: Safe Medication Use in the ICU",
abstract = "This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.",
keywords = "critical care intensive care unit, drug-related side effects and adverse reactions, medication errors, patient safety, safety management",
author = "Kane-Gill, {Sandra L.} and Dasta, {Joseph F.} and Buckley, {Mitchell S.} and Sandeep Devabhakthuni and Michael Liu and Henry Cohen and George, {Elizabeth L.} and Pohlman, {Anne S.} and Swati Agarwal and Henneman, {Elizabeth A.} and Bejian, {Sharon M.} and Sean Berenholtz and Pepin, {Jodie L.} and Scanlon, {Mathew C.} and Smith, {Brian S.}",
year = "2017",
month = "9",
day = "1",
doi = "10.1097/CCM.0000000000002519",
language = "English (US)",
volume = "45",
pages = "1546--1551",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Executive Summary

T2 - Clinical Practice Guideline: Safe Medication Use in the ICU

AU - Kane-Gill, Sandra L.

AU - Dasta, Joseph F.

AU - Buckley, Mitchell S.

AU - Devabhakthuni, Sandeep

AU - Liu, Michael

AU - Cohen, Henry

AU - George, Elizabeth L.

AU - Pohlman, Anne S.

AU - Agarwal, Swati

AU - Henneman, Elizabeth A.

AU - Bejian, Sharon M.

AU - Berenholtz, Sean

AU - Pepin, Jodie L.

AU - Scanlon, Mathew C.

AU - Smith, Brian S.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

AB - This is the first clinical guideline to evaluate the safe use of medications in the ICU. The ICU environment as a risk for medication-related events and environmental changes that can improve safe medication use is appraised. Prevention strategies for medication-related events are reviewed at the medication use process nodes. Considerations for an active surveillance system that includes reporting, identification, and evaluation are discussed. Also, highlighted in this document is the need for future research related to important safe medication practices such as medication reconciliation and double-checking during medication administration.

KW - critical care intensive care unit

KW - drug-related side effects and adverse reactions

KW - medication errors

KW - patient safety

KW - safety management

UR - http://www.scopus.com/inward/record.url?scp=85032358778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032358778&partnerID=8YFLogxK

U2 - 10.1097/CCM.0000000000002519

DO - 10.1097/CCM.0000000000002519

M3 - Article

C2 - 28816838

AN - SCOPUS:85032358778

VL - 45

SP - 1546

EP - 1551

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 9

ER -